In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
In October 2019, a class-action lawsuit was filed against Sanofi-Aventis U.S., Sanofi US Services, Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals for allegedly failing to disclose that the over-the-counter heartburn medication…
For man and beast alike, good food is a matter of perspective.
Promotion for purported testosterone booster has some hard-to-believe claims.
Adidas, Coca-Cola, Visa and … OnPassive?
TINA.org submits comment to FTC urging further revisions to stay relevant and effective.
Stardust marketing claims out of this world